BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 21091017)

  • 1. A review of current technology used in evaluating visual function in glaucoma.
    Turalba AV; Grosskreutz C
    Semin Ophthalmol; 2010; 25(5-6):309-16. PubMed ID: 21091017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal/noise analysis to compare tests for measuring visual field loss and its progression.
    Artes PH; Chauhan BC
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4700-8. PubMed ID: 19458326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of visual function in glaucoma: a report by the American Academy of Ophthalmology.
    Jampel HD; Singh K; Lin SC; Chen TC; Francis BA; Hodapp E; Samples JR; Smith SD
    Ophthalmology; 2011 May; 118(5):986-1002. PubMed ID: 21539982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal/noise ratios to compare tests for measuring visual field progression.
    Ernest PJ
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6893; author reply 6893-4. PubMed ID: 21123778
    [No Abstract]   [Full Text] [Related]  

  • 6. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH; Hutchison DM; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard automated perimetry and algorithms for monitoring glaucoma progression.
    Scuderi GL; Cesareo M; Perdicchi A; Recupero SM
    Prog Brain Res; 2008; 173():77-99. PubMed ID: 18929103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The psychophysics of glaucoma: improving the structure/function relationship.
    Anderson RS
    Prog Retin Eye Res; 2006 Jan; 25(1):79-97. PubMed ID: 16081311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting visual field tests and assessing visual field deterioration in glaucoma.
    Nouri-Mahdavi K
    Can J Ophthalmol; 2014 Dec; 49(6):497-505. PubMed ID: 25433738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interobserver agreement and intraobserver reproducibility of the subjective determination of glaucomatous visual field progression.
    Tanna AP; Bandi JR; Budenz DL; Feuer WJ; Feldman RM; Herndon LW; Rhee DJ; Whiteside-de Vos J
    Ophthalmology; 2011 Jan; 118(1):60-5. PubMed ID: 20723992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can frequency-doubling technology and short-wavelength automated perimetries detect visual field defects before standard automated perimetry in patients with preperimetric glaucoma?
    Ferreras A; Polo V; Larrosa JM; Pablo LE; Pajarin AB; Pueyo V; Honrubia FM
    J Glaucoma; 2007; 16(4):372-83. PubMed ID: 17571000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of frequency-doubling technology for perimetrically normal eyes of open-angle glaucoma patients with unilateral field loss.
    Fan X; Wu LL; Ma ZZ; Xiao GG; Liu F
    Ophthalmology; 2010 Aug; 117(8):1530-7, 1537.e1-2. PubMed ID: 20466428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What reduction in standard automated perimetry variability would improve the detection of visual field progression?
    Turpin A; McKendrick AM
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3237-45. PubMed ID: 21357405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of functional visual field loss by automated static perimetry.
    Frisén L
    Acta Ophthalmol; 2014 Dec; 92(8):805-9. PubMed ID: 24698019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting glaucoma progression by white-on-white perimetry.
    Tan JC; Franks WA; Hitchings RA
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):585-92. PubMed ID: 12136293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rarebit perimetry for bedside testing: comparison with standard automated perimetry.
    Steven Houston SK; Weber ED; Koga SF; Newman SA
    J Neuroophthalmol; 2010 Sep; 30(3):243-7. PubMed ID: 20548245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of progressive change in automated visual fields in glaucoma.
    Smith SD; Katz J; Quigley HA
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1419-28. PubMed ID: 8641844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.
    Haymes SA; Hutchison DM; McCormick TA; Varma DK; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):547-54. PubMed ID: 15671281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The groningen longitudinal glaucoma study III. The predictive value of frequency-doubling perimetry and GDx nerve fibre analyser test results for the development of glaucomatous visual field loss.
    Heeg GP; Jansonius NM
    Eye (Lond); 2009 Aug; 23(8):1647-52. PubMed ID: 19011607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.